Allergic Rhinitis Drugs Global Market Report 2024

Description

Allergic rhinitis drugs are medications used to alleviate symptoms of allergic rhinitis, a condition marked by inflammation of the nasal passages due to allergens such as pollen, dust, mold, or animal dander. These drugs help relieve symptoms such as sneezing, itching, nasal congestion, and a runny nose.

The main types of allergic rhinitis covered by these drugs include seasonal allergic rhinitis, perennial allergic rhinitis, and occupational allergic rhinitis. Seasonal allergic rhinitis, often referred to as hay fever, occurs at specific times of the year when allergens such as pollen from trees, grasses, or weeds are prevalent. Treatments for allergic rhinitis include antihistamines, immunotherapy, corticosteroids, decongestants, and other medications. These treatments can be administered through various routes, including oral, nasal, intraocular, and intravenous methods. They are distributed through channels such as retail pharmacies, hospital pharmacies, and online platforms.

The allergic rhinitis drugs market research report is one of a series of new reports from The Business Research Company that provides allergic rhinitis drugs market statistics, including allergic rhinitis drugs industry global market size, regional shares, competitors with an allergic rhinitis drugs market share, detailed allergic rhinitis drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the allergic rhinitis drugs industry. This allergic rhinitis drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The allergic rhinitis drugs market size has grown steadily in recent years. It will grow from $14.99 billion in 2023 to $15.67 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth during the historic period can be attributed to rising awareness about allergic reactions and treatment options, an increasing prevalence of allergic rhinitis, heightened demand for effective medications, and the growing popularity of over-the-counter (OTC) allergy treatments.

The allergic rhinitis drugs market size is expected to see steady growth in the next few years. It will grow to $18.78 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to rising pollution levels and an increase in respiratory disorders, growing environmental pollution, changing climatic conditions, a higher number of individuals suffering from allergies, and increasing awareness about allergic reactions and available treatments. Major trends during this period include technological advancements in treatment methods, the development of new antihistamines, innovations in allergy rhinitis diagnostics, progress in allergy treatment, and increased research and development of new therapies.

The increasing incidence of respiratory disorders is expected to drive the growth of the allergic rhinitis drug market. Respiratory disorders include a variety of conditions that impact the lungs and airways. This rise is largely attributed to greater exposure to environmental pollutants, such as air pollution and allergens, along with climate change and a higher prevalence of respiratory infections. Allergic rhinitis drugs are crucial for managing these disorders, as they reduce inflammation and alleviate symptoms such as nasal congestion and sneezing, thus improving respiratory function. For example, in April 2024, the Centers for Disease Control and Prevention, a US-based governmental body, reported that the percentage of adults with current asthma increased from 8.0% in 2021 to 8.9% in 2023. Consequently, the growing prevalence of respiratory disorders is fueling the growth of the allergic rhinitis drug market.

Leading companies in the allergic rhinitis drug market are concentrating on innovative treatment methods, such as novel fixed-dose combinations, to stay competitive. These treatments combine several active ingredients into a single, pre-measured dose, aiming to enhance efficacy, simplify administration, and improve patient adherence. For instance, in May 2021, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical firm, introduced the Ryaltris-AZ Nasal Spray. This fixed-dose combination includes Mometasone Furoate 50 mcg and Azelastine 140 mcg and is designed to treat moderate to severe allergic rhinitis in India. The nasal spray delivers higher drug concentrations directly to the site of inflammation, potentially reducing systemic side effects compared to oral treatments.

In January 2022, Glenmark Pharmaceuticals Limited formed a partnership with Lotus Pharmaceutical Co. Ltd. to extend the market reach of Ryaltris into Singapore, Hong Kong, and Vietnam. This collaboration allows Glenmark to utilize Lotus's established network in Southeast Asia for the introduction of Ryaltris, while Lotus will manage commercialization, pending regulatory approvals to ensure compliance and facilitate market entry. Lotus Pharmaceutical Co. Ltd. is a Taiwan-based pharmaceutical company.

Major companies operating in the allergic rhinitis drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Sanofi SA, AstraZeneca plc, Novartis AG, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories, Apotex Inc., Meda AB, Amneal Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd, ALK-Abello A/S, Stallergenes Greer plc, Himalaya Wellness Company, Unichem Laboratories Limited, Aytu BioPharma Inc., Allergy Therapeutics PLC, DMK Pharmaceuticals Corporation, Revolo Biotherapeutics

Asia-Pacific was the largest region in the allergic rhinitis drugs market in 2023. The regions covered in the allergic rhinitis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the allergic rhinitis drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The allergic rhinitis drugs market consists of sales of mast cell stabilizers, drops, and saline nasal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergic Rhinitis Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergic rhinitis drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergic rhinitis drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The allergic rhinitis drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
2) By Treatment: Antihistamines; Immunotherapy; Corticosteroids; Decongestants; Other Treatments
3) By Route Of Administration: Oral; Nasal; Intraocular; Intravenous
4) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Online Channel
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Bayer AG; Sanofi SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19532

1. Executive Summary

2. Allergic Rhinitis Drugs Market Characteristics

3. Allergic Rhinitis Drugs Market Trends And Strategies

4. Allergic Rhinitis Drugs Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Allergic Rhinitis Drugs Market Size and Growth

5.1. Global Allergic Rhinitis Drugs Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Allergic Rhinitis Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Allergic Rhinitis Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Allergic Rhinitis Drugs Market Segmentation

6.1. Global Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Seasonal Allergic Rhinitis
Perennial Allergic Rhinitis
Occupational Allergic Rhinitis
6.2. Global Allergic Rhinitis Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antihistamines
Immunotherapy
Corticosteroids
Decongestants
Other Treatments
6.3. Global Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Nasal
Intraocular
Intravenous
6.4. Global Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Retail Pharmacies
Hospital Pharmacies
Online Channel

7. Allergic Rhinitis Drugs Market Regional And Country Analysis

7.1. Global Allergic Rhinitis Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Allergic Rhinitis Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Allergic Rhinitis Drugs Market

8.1. Asia-Pacific Allergic Rhinitis Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Allergic Rhinitis Drugs Market

9.1. China Allergic Rhinitis Drugs Market Overview
9.2. China Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Allergic Rhinitis Drugs Market

10.1. India Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Allergic Rhinitis Drugs Market

11.1. Japan Allergic Rhinitis Drugs Market Overview
11.2. Japan Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Allergic Rhinitis Drugs Market

12.1. Australia Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Allergic Rhinitis Drugs Market

13.1. Indonesia Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Allergic Rhinitis Drugs Market

14.1. South Korea Allergic Rhinitis Drugs Market Overview
14.2. South Korea Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Allergic Rhinitis Drugs Market

15.1. Western Europe Allergic Rhinitis Drugs Market Overview
15.2. Western Europe Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Allergic Rhinitis Drugs Market

16.1. UK Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Allergic Rhinitis Drugs Market

17.1. Germany Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Allergic Rhinitis Drugs Market

18.1. France Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Allergic Rhinitis Drugs Market

19.1. Italy Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Allergic Rhinitis Drugs Market

20.1. Spain Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Allergic Rhinitis Drugs Market

21.1. Eastern Europe Allergic Rhinitis Drugs Market Overview
21.2. Eastern Europe Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Allergic Rhinitis Drugs Market

22.1. Russia Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Allergic Rhinitis Drugs Market

23.1. North America Allergic Rhinitis Drugs Market Overview
23.2. North America Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Allergic Rhinitis Drugs Market

24.1. USA Allergic Rhinitis Drugs Market Overview
24.2. USA Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Allergic Rhinitis Drugs Market

25.1. Canada Allergic Rhinitis Drugs Market Overview
25.2. Canada Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Allergic Rhinitis Drugs Market

26.1. South America Allergic Rhinitis Drugs Market Overview
26.2. South America Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Allergic Rhinitis Drugs Market

27.1. Brazil Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Allergic Rhinitis Drugs Market

28.1. Middle East Allergic Rhinitis Drugs Market Overview
28.2. Middle East Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Allergic Rhinitis Drugs Market

29.1. Africa Allergic Rhinitis Drugs Market Overview
29.2. Africa Allergic Rhinitis Drugs Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Allergic Rhinitis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Allergic Rhinitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Allergic Rhinitis Drugs Market Competitive Landscape And Company Profiles

30.1. Allergic Rhinitis Drugs Market Competitive Landscape
30.2. Allergic Rhinitis Drugs Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Sanofi SA
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Allergic Rhinitis Drugs Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. Novartis AG
31.3. GlaxoSmithKline PLC
31.4. Boehringer Ingelheim International GmbH
31.5. Viatris Inc.
31.6. Teva Pharmaceutical Industries Ltd.
31.7. Regeneron Pharmaceuticals Inc.
31.8. Bausch Health Companies Inc.
31.9. Sun Pharmaceuticals Industries Ltd.
31.10. Perrigo Company plc
31.11. Dr. Reddy's Laboratories
31.12. Apotex Inc.
31.13. Meda AB
31.14. Amneal Pharmaceuticals Inc.
31.15. Glenmark Pharmaceuticals Ltd

32. Global Allergic Rhinitis Drugs Market Competitive Benchmarking

33. Global Allergic Rhinitis Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Allergic Rhinitis Drugs Market

35. Allergic Rhinitis Drugs Market Future Outlook and Potential Analysis

35.1 Allergic Rhinitis Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Allergic Rhinitis Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Allergic Rhinitis Drugs Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer